Psilocybin, acting as an agonist at serotonin 5-HT2A/C and 5-HT1A receptors [1] is known to mimic positive-like symptoms and, thus, it is also used as a serotoninergic model of psychosis [27,40]. The gene discussed is HTR1A; the disease is psychotic disorder.